FCGRT and chronic inflammatory demyelinating polyradiculoneuropathy: This study aimed to investigate the therapeutic potential of an antibody targeting FcRn in the intracellular adhesion molecule 1 (ICAM1)-deficient NOD mouse—a model representative for many aspects of human CIDP.